Channelled tablets: An innovative approach to accelerating drug release from 3D printed tablets

Abstract Conventional immediate release dosage forms involve compressing the powder with a disintegrating agent that enables rapid disintegration and dissolution upon oral ingestion. Among 3D printing technologies, the fused deposition modelling (FDM) 3D printing technique has a considerable potential for patient‐specific dosage forms. However, the use of FDM 3D printing in tablet manufacturing requires a large portion of polymer, which slows down drug release through erosion and diffusion mechanisms. In this study, we demonstrate for the first time the use of a novel design approach of caplets with perforated channels to accelerate drug release from 3D printed tablets. This strategy has been implemented using a caplet design with perforating channels of increasing width (0.2, 0.4, 0.6, 0.8 or 1.0 mm) and variable length, and alignment (parallel or at right angle to tablet long axis). Hydrochlorothiazide (BCS class IV drug) was chosen as the model drug as enhanced dissolution rate is vital to guarantee oral bioavailability. The inclusion of channels exhibited an increase in the surface area/volume ratio, however, the release pattern was also influenced by the width and the length of the channel. A channel width was ≥ 0.6 mm deemed critical to meet the USP criteria of immediate release products. Shorter multiple channels (8.6 mm) were more efficient at accelerating drug release than longer channels (18.2 mm) despite having comparable surface area/mass ratio. This behaviour may be linked to the reduced flow resistance within the channels and the faster fragmentation during dissolution of these tablets. In conclusion, the width and length of the channel should be carefully considered in addition to surface area/mass when optimizing drug release from 3D printed designs. The incorporation of short channels can be adopted in the designs of dosage forms, implants or stents to enhance the release rate of eluting drug from polymer‐rich structures. Graphical abstract Figure. No Caption available.

[1]  A. Hussain,et al.  Polymer erosion and drug release characterization of hydroxypropyl methylcellulose matrices. , 1998, Journal of pharmaceutical sciences.

[2]  L. Augsburger,et al.  The Influence of Product Brand-to-Brand Variability on Superdisintegrant Performance A Case Study with Croscarmellose Sodium , 2006, Pharmaceutical development and technology.

[3]  H. Yuasa,et al.  Studies on the Development of Intragastric Floating and Sustained Release Preparation. I. Application of Calcium Silicate as a Floating Carrier , 1996 .

[4]  N. Rasenack,et al.  Dissolution Rate Enhancement by in Situ Micronization of Poorly Water-Soluble Drugs , 2002, Pharmaceutical Research.

[5]  Waqar Ahmed,et al.  Emergence of 3D Printed Dosage Forms: Opportunities and Challenges , 2016, Pharmaceutical Research.

[6]  Federico Parietti,et al.  Hot-melt extruded filaments based on pharmaceutical grade polymers for 3D printing by fused deposition modeling. , 2016, International journal of pharmaceutics.

[7]  K. Fukushige,et al.  3D Printing Factors Important for the Fabrication of Polyvinylalcohol Filament-Based Tablets. , 2017, Biological & pharmaceutical bulletin.

[8]  M. A. Alhnan,et al.  Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing. , 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[9]  Michael A Repka,et al.  Characterization of cellulosic hot-melt extruded films containing lidocaine. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[10]  Vasanthakumar Sekar,et al.  Immediate release tablets of telmisartan using superdisintegrant-formulation, evaluation and stability studies. , 2008, Chemical & pharmaceutical bulletin.

[11]  Hongyu Chai,et al.  Fused Deposition Modeling (FDM) 3D Printed Tablets for Intragastric Floating Delivery of Domperidone , 2017, Scientific Reports.

[12]  C Vervaet,et al.  Co-extrusion as manufacturing technique for fixed-dose combination mini-matrices. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[13]  Simon Gaisford,et al.  Fabrication of controlled-release budesonide tablets via desktop (FDM) 3D printing. , 2015, International journal of pharmaceutics.

[14]  M. Cima,et al.  Oral dosage forms fabricated by three dimensional printing. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[15]  Waqar Ahmed,et al.  Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets. , 2016, International journal of pharmaceutics.

[16]  Simon Gaisford,et al.  3D Printing of Medicines: Engineering Novel Oral Devices with Unique Design and Drug Release Characteristics. , 2015, Molecular pharmaceutics.

[17]  Michael A Repka,et al.  Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets. , 2017, International journal of pharmaceutics.

[18]  J. Lewis,et al.  Printing soft matter in three dimensions , 2016, Nature.

[19]  G. Cole Introduction and overview of pharmaceutical coating , 1995 .

[20]  A. Basit,et al.  1 3 D printing : Engineering novel oral devices with unique design and drug release characteristics , 2015 .

[21]  Keith P. Johnston,et al.  Enhanced Aqueous Dissolution of a Poorly Water Soluble Drug by Novel Particle Engineering Technology: Spray-Freezing into Liquid with Atmospheric Freeze-Drying , 2003, Pharmaceutical Research.

[22]  A. Basit,et al.  3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[23]  R. Davé,et al.  Simultaneous micronization and surface modification for improvement of flow and dissolution of drug particles. , 2011, International journal of pharmaceutics.

[24]  A. Basit,et al.  Fused-filament 3D printing (3DP) for fabrication of tablets. , 2014, International journal of pharmaceutics.

[25]  G. Desiraju,et al.  Cocrystals of Hydrochlorothiazide: Solubility and Diffusion/Permeability Enhancements through Drug-Coformer Interactions. , 2015, Molecular pharmaceutics.

[26]  L. Augsburger,et al.  Multiple Sources of Sodium Starch Glycolate, NF: Evaluation of Functional Equivalence and Development of Standard Performance Tests , 2002, Pharmaceutical development and technology.

[27]  Emanuel M. Sachs,et al.  Solid free-form fabrication of drug delivery devices , 1996 .

[28]  B. Arafat,et al.  A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets , 2016, Pharmaceutical Research.

[29]  J. Breitkreutz,et al.  Individual Oral Therapy with Immediate Release and Effervescent Formulations Delivered by the Solid Dosage Pen , 2012, Journal of personalized medicine.

[30]  A. Basit,et al.  Effect of geometry on drug release from 3D printed tablets. , 2015, International journal of pharmaceutics.

[31]  Deng-Guang Yu,et al.  Novel oral fast-disintegrating drug delivery devices with predefined inner structure fabricated by Three-Dimensional Printing. , 2009, The Journal of pharmacy and pharmacology.

[32]  M. Alexander,et al.  Desktop 3D printing of controlled release pharmaceutical bilayer tablets. , 2014, International journal of pharmaceutics.

[33]  G. Regdon,et al.  Physicochemical characterisation and investigation of the bonding mechanisms of API-titanate nanotube composites as new drug carrier systems. , 2017, International journal of pharmaceutics.

[34]  L. Rajput,et al.  Tuning solubility and stability of hydrochlorothiazide co-crystals. , 2014, Acta crystallographica Section B, Structural science, crystal engineering and materials.

[35]  C Caramella,et al.  Dissolution enhancement of an insoluble drug by physical mixture with a superdisintegrant: optimization with a simplex lattice design. , 1996, Pharmaceutical development and technology.

[36]  C. Scarpignato,et al.  Esomeprazole immediate release tablets: Gastric mucosa ex vivo permeation, absorption and antisecretory activity in conscious rats. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[37]  P. Verma,et al.  Controlled Porosity Solubility Modulated Osmotic Pump Tablets of Gliclazide , 2014, AAPS PharmSciTech.

[38]  J. V. Levy,et al.  Effervescent Morphine Results in Faster Relief of Breakthrough Pain in Patients Compared to Immediate Release Morphine Sulfate Tablet , 2007, Pain practice : the official journal of World Institute of Pain.

[39]  M. A. Alhnan,et al.  A flexible-dose dispenser for immediate and extended release 3D printed tablets. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[40]  Simon Gaisford,et al.  Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing. , 2017, International journal of pharmaceutics.

[41]  Sara McMains Layered manufacturing technologies , 2005, CACM.